AI has the potential to transform healthcare through tools that streamline tasks, support diagnosis, and guide clinical decisions, but bias in these models poses risks of patient harm. This article highlights the issue of bias, its clinical consequences, and introduces a simple framework to mitigate it.
Join moderator Krishna Pundi and guests Mike Rosenberg, Peter Noseworthy, and Demilade Adedinsewo for a lively discussion of this cutting-edge manuscript from heart Rhythm O2.
Learning Objectives
Examine biases that create potential risks for patients in the use of AI tools in healthcare.
Podcast Contributors
Krishna Pundi, MD, Stanford University/Palo Alto VA Medical Center
Mike Rosenberg, MD, FHRS, University of Colorado Anschutz
Peter Noseworthy, MD, FHRS, Mayo Clinic
Demilade Adedinsewo, MD, MPH, Mayo Clinic
Faculty and Disclosures
All relevant financial relationships have been mitigated.
Host Disclosure(s):
K. Pundi:
Nothing to disclose.
Contributors Disclosure(s):
M. Rosenberg:
Nothing to disclose.
P. Noseworthy:
Honoraria/Speaking/Consulting: Optum
Research: National Institutes of Health, National Institute on Aging, Agency for Healthcare Research and Quality, U.S. Food & Drug Administration, American Heart Association, Medtronic, Inc.
Royalty: AliveCor,
D. Adedinsewo:
Research: NIH, Miami Heart Research Institute
Fellowship: Mayo Clinic
Stocks Publicly Traded: Apple
Listen on:
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 153: A Discussion of Exercise Capacity and Quality-of-Life Improvements after Catheter Ablation in Patients with Clinically Asymptomatic Persistent Atrial Fibrillation
May 28, 2026
The Lead
Podcasts
The Lead Episode 151: Heart Rhythm 2026 Late-Breaker Coverage: A Discussion of Outcomes of Left Atrial Appendage Closure versus Oral Anticoagulation in Patients with Atrial Fibrillation and Prior Ablation: A Sub-Analysis of the CHAMPION-AF Clinical Trial
May 21, 2026
The Lead
Podcasts
The Lead Episode 152: A Discussion of Outcomes of Left Atrial Appendage Closure versus Oral Anticoagulation in Patients with Atrial Fibrillation and Prior Ablation: A Sub-Analysis of the CHAMPION-AF Clinical Trial (NEJM)
May 21, 2026